Effect of erythrocytes and prostacyclin production in the effect of fructose and sorbitol on platelet activation in human whole blood in vitro

Thrombosis Research

Volumn 86, Issue 6, 1997, Pages 515-524

  De La Cruz M, José Pedro ^a   Maximo, Antonia ^a   Blanco, Encarnación ^a   Moreno, Antonio ^a   De La Cuesta, Felipe Sánchez ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

Erythrocytes; Fructose; Platelets; Prostacyclin; Sorbitol

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ADENOSINE; ADENOSINE DIPHOSPHATE; CARBON 14; COLLAGEN; FRUCTOSE; PROSTACYCLIN; SORBITOL; THROMBOXANE B2;

ADULT; ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; ERYTHROCYTE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERGLYCEMIA; LIPID PEROXIDATION; MALE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RAT; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE RICH PLASMA;

6-KETOPROSTAGLANDIN F1 ALPHA; ADENOSINE; ADENOSINE DIPHOSPHATE; ADULT; ANIMALS; AORTA; BLOOD GLUCOSE; BLOOD PLATELETS; COLLAGEN; DIABETIC ANGIOPATHIES; EPOPROSTENOL; ERYTHROCYTES; FRUCTOSE; HUMANS; HYPERGLYCEMIA; LIPID PEROXIDATION; MALE; PLATELET ACTIVATION; PLATELET AGGREGATION; RATS; RATS, WISTAR; SORBITOL; THROMBOXANE B2;

EID: 0030849778     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(97)00100-X     Document Type: Article

References (23)

1. KROLEWSKI A.S., WARRAN J.H., RNAD L.I., CHRISTLIEB A.R., BUSICK E.J., KAHN C.R. Risk of proliferative diabetic retinopathy in juvenile onset type I diabetes. Diabetes Care. 9:1986;443-452.
2. MERIMEE T.J. Diabetic retinopathy: a synthesis of perspectives. N Engl J Med. 322:1990;978-983.
3. CLEMENTS R.S., BELL D.S.H. Complications of diabetes. Am J Med. 79:1985;2-7.
4. ISHII H., UMEDA F., NAWATA H. Platelet function in diabetes mellitus. Diabetes/Metabolism Reviews. 8:1992;53-66.
5. CARDINAL D.C., FLOWER R.J. The electronic aggregometer: a novel device for assessing platelet behaviour in blood. J Pharm Meth. 3:1980;135-158.
6. YAGI K. Lipid Peroxides in Biology and Medicine. Academic Press, San Diego. pp 223-242, 1982.
7. GRESELE P., ZOJA C., DECKMYN H., ARNOUT J., VERMYLEN J., VERSTRAETE M. Dipyridamole inhibits platelet aggregation in whole blood. Thromb Haemostas. 50:1983;852-860.
8. DE LA CRUZ J.P., ORTEGA G., SANCHEZ DE LA CUESTA F. Differential effects of the pyrimido-pyrimidine derivatives, dipyridamole and mopidamol, on platelet and vascular cyclooxygenase activity. Biochem Pharmacol. 47:1994;209-215.
9. DE LA CRUZ J.P., CAMARA S., BELLIDO I., CARRASCO T., SANCHEZ DE LA CUESTA F. Platelet aggregation in human whole blood after chronic administration of aspirin. Thromb Res. 46:1987;133-140.
10. DE LA CRUZ J.P., ROMERO M.M., SANCHEZ P., SANCHEZ DE LA CUESTA F. Antiplatelet effects of pentoxifylline in human whole blood. Gen Pharmacol. 24:1993;605-609.
11. DE LA CRUZ J.P., PAVIA J., BELLIDO I., SANCHEZ DE LA CUESTA F. Effects of triflusal and acetylsalicylic acid on platelet aggregation in human whole blood: influence of red blood cells and leukocytes. Meth Find Exptl Clin Pharmacol. 10:1988;363-367.
12. MARCUS A.J., SAFIER L.B., ULLMAN H.L.et al. Interaction between platelets and neutrophils in the eicosanoid pathway. Adv Prost Throm Leu Res. 19:1989;263-266.
13. CAVALLINI I., DEANA R., FRANCESCONI M.A., ALEXANDRE A. Fructose-1,6-diphosphate inhibits platelet aggregation. Biochem Pharmacol. 43:1991;1539-1544.
14. LOESCHE W., BEVAN J., MICHEL E., BURCHARDT A., HEPTINSTALL S. Effects of glucose on platelet aggregation in whole blood. Diab Nutr Metab. 3:1988;209-214.
15. MAY J., LOESCHE W., HEPTINSTALL S. Glucose increased spontaneous platelet aggregation in whole blood. Thromb Res. 59:1990;489-495.
16. HEPTINSTALL S., FOX S., CRAWFORD J., HAWKINS M. Inhibition of platelet aggregation in whole blood by dipyridamole and aspirin. Thromb Res. 42:1986;215-223.
17. HAMADA Y., KITOH R., RASKIN P. Crucial role of aldose-reductase activity and plasma glucose in sorbitol accumulation in erythrocytes from diabetic patients. Diabetes. 40:1991;1233-1240.
18. LOESCHE W., MAY J., HEPTINSTALL S. High concentrations of glucose impair red blood cell membrane integrity. Studia Biophysica. 134:1990;87-89.
19. MALONE J.L., KNOX G., BENFORD S., TEDESCO T.A. Red cell sorbitol: an indicator of diabetic control. Diabetes. 29:1980;861-864.
20. DE LA CRUZ J.P., MORENO A., GARCIA CAMPOS J.M., SANCHEZ DE LA CUESTA F. Hyperactivity of platelet function in human diabetes mellitus is different according to the type of retinopathy. Vis Res. 35:1995;P334.
21. WINOCOUR P.D. Platelet abnormalities in diabetes mellitus. Diabetes. 41(suppl 2):1992;26-31.
22. MORENO A., DE LA CRUZ J.P., GARCIA CAMPOS J.M., SANCHEZ DE LA CUESTA F. Prostacyclin/thromboxane balance and retinal vascular pattern in diabetic rats. Can J Ophthalmol. 30:1995;117-123.
23. WARSO M., LANDS W. Lipid peroxidation in relation to prostacyclin and thromboxane: physiology and pathophysiology. Br Med Bul. 39:1983;277-280.